The IFN-b-inducing effect of c-di-AMP contributes, at least in part, to the reported proliferation of antigen-specific T cell types and the evolvement of the proposed balanced TH1/TH2/TH17 cell response. DC subset targeting was investigated also with regard to the c-di-AMPinduced IFN-b production. Conventional DCs showed a much more pronounced IFN-b production than plasmacytoid DCs. This finding was somewhat surprising because plasmacytoid DCs are known to be specialized in IFN type I production and usually produce these IFNs in much higher amounts than conventional DCs, which are specialized in antigen presentation. By targeting conventional DCs, c-di-AMP evokes the secretion of a rather limited amount of IFN-b which may be important to fine tune immune responses. Interestingly, also the IFN-b response to L. monocytogenes was reported not to be mediated by plasmacytoid DCs either. Since it is known that the bacterium secretes c-di-AMP in the course of infection, our results further strengthen the suggestion that c-di-AMP is indeed the mediator of the L. monocytogenes-induced IFN-b. The modes of action described here do not exclude additional, not yet identified mechanisms of c-di-AMP-mediated immune response modulation. For example, other co-stimulatory molecules or secreted immune signaling molecules could be regulated in a cdi-AMP-dependent manner to enhance or modulate antigeninduced immune responses by acting on either effector or bystander cells. However, our results further elucidate intermediate steps of the immune response cascade leading to the immune modulatory activity of c-di-AMP observed in immunization studies on mice. They advance the knowledge on modes of adjuvant action toward the regulation of effective immunization responses. Transcription Activator-Like Effectors technology comprises a rapidly developing tool for targeted genome manipulation. Deciphering of the TALE DNA recognition code in 2009 led to the development of a series of novel engineered TALE chimeras for a variety of purposes. For example, TALEs have been engineered to modulate gene expression, reprogram epigenetic modifications, repair or disrupt genes using TALENs or chimeric TALE recombinases, and promote targeted gene transposition using TALE-directed piggyBac. TALEs offer an attractive advantage over traditional zinc finger-based technologies due to their inherently simple and predictable DNA recognition code attributed to its novel type DNA-binding domain. The TALE DBD is highly repetitive and contains a tandem array of repeat monomers with each monomer consisting of,34 amino acids with the exception of the last repeat unit consisting of,20 amino acids. Relative to TALENs, the potential of TALEs as activators has not been fully explored until more recently. Initial studies showed that a single TALE activator was able to drive the expression of a reporter gene linked to a synthetic promoter derived from different cellular genes.

In agreement with our nutrigenomic results, a significant decreased adhesion of monocytes pre-exposed to MOF could be observed at the endothelial cells compared to control. The potential of grape seed extract to decrease adhesion of monocytes to HUVECs has been reported recently, however at concentrations ranging from 50 to 100 mg/ml. These concentrations are higher than the concentrations used in our study. Our results emphasize the capacity of grape seed– derived MOF to decrease the adhesion of immune cells to the vascular endothelium and potentially lower infiltration of these immune cells into the vascular wall, which is an initial step in atherosclerosis development. It has been reported that supplementation of the diet with catechin, a flavanol monomer present in MOF, results in lower atherosclerosis development in apolipoprotein E-deficient mice. It could be postulated that the regular consumption of MOF could decrease blood cell infiltration into the vasculature and potentially protect against atherosclerotic lesions in humans. Our bioinformatic data also revealed that over 30 differentially expressed genes are involved in different processes related to inflammation. The role of chronic inflammation in the promotion, initiation and development of chronic diseases, such as cancer, cardiovascular disease or osteoporosis has been described. In our study, among the differentially expressed genes involved in inflammatory processes is the gene coding for the proinflammatory cytokine IL2, of which the expression has been down-regulated by the MOF supplementation. Together with IL2, we also observed a decrease in the expression of a subunit of its receptor, the IL2RB gene. These inflammation-related genes, as well as some of the cell adhesion molecules, are regulated by the transcription factor NF-kB. Bioinformatic analyses of the nutrigenomic data identified several transcription factors potentially involved in the regulation of the expression of differentially expressed genes, among which is NF-kB. This suggests that NF-kB is a potential target by which MOF exert their anti-inflammatory effects in circulating blood cells. Interestingly, our nutrigenomic data also revealed an increase in the expression of the gene coding for NFKBIA, the endogenous inhibitor of NF-kB. A previous in vivo study in an atherosclerotic ApoE mouse model identified NF-kB as a major upstream regulator in leukocyte adhesion and transendothelial migration through the vascular endothelium. Moreover, NF-kB activity in peripheral blood mononuclear cells from smokers has been found to be significantly higher than in PBMCs from non-smokers. In order to corroborate a direct effect of MOF on NF-kB we performed NF-kB reporter gene studies in an inflammatory human monocyte/macrophage cell model. The experiments revealed a dose- and time-dependent repression of NF-kB luciferase expression in the presence of MOF.

A key inhibitor of osteoclast activity, osteoprotegrin, is normally enriched in the cochlea relative to other sites in the body. In mice, OPG is produced at high levels by fibrocytes within the spiral ligament and secreted in the perilymph. Mice deficient in OPG show excessive remodeling throughout the middle and inner ear resulting in severe hearing loss. While there are cases of FD causing sensorineural hearing loss in humans, it has been hypothesized that this is due to auditory neural compression from the FD bone changes. The results in our mouse model with FD like lesions would support that mechanism, as well as possibly physical changes to the ossicular chain, as opposed to pathologic changes of sensory structures as seen in such lesions as cochlear otosclerosis. These results point to a role for peri-lacunar remodeling in the cochlea that may be disrupted in FD. In conclusion, our results show that the cochlea is a unique bony structure characterized by limited bone turnover that confers protection from proliferative and metabolically active FD bony lesions. The invasive fibro-osseous lesions seen in this mouse model cause conductive hearing loss through involvement of the ossicular chain, in a manner very similar to that seen in humans. These mechanisms could be new pharmacologic targets to treat the skeletal or hearing manifestations of FD or other skeletal diseases. The vitrification process plays a key role in cryopreservation for the long term conservation of plant genetic resources. Vitrification is defined as a physical process by which a concentrated aqueous solution solidifies into a stable amorphous glass without the formation of ice crystals when the temperature is decreased. Vitrification of plant specimens can be achieved in many ways, including air drying of embryos, and more recently through the use of highly concentrated plant vitrification solutions that readily form glasses on cooling and inhibit crystallization. However, exposure to PVS must be controlled to enable sufficient cellular dehydration whilst limiting injury from chemical toxicity and establishment of a simple and high-throughput cryopreservation method using cryoprotectant is highly desirable. Plant vitrification solutions combine cryoprotectants that vary in permeability, such that cellular water is replaced, cell viscosity is increased and the freezing behaviour of the remaining water is altered. PVS2 is probably the most commonly used cryoprotectant for plant cells, tissues and embryos; for example, the cryopreservation of embryonic axes of citrus and in vitro shoot-tips of Parkia speciosa, a tropical species with recalcitrant seeds. The conventional approach to vitrification generally involves a tissue pre-culture step on sucrose-enriched medium, before cooling, with highly concentrated vitrification solution for a period that varies with species, tissue and temperature.

Signal during exposition with a quantitative imaging system, as these systems are often calibrated to stop the exposure process before the strongest signal on the membrane is outside the linear range of detection. We, therefore, recommend to mask the non-specific signal at 25 kDa, or to cut the membrane prior to incubation with secondary anti-LC antibodies, or to do incremental exposure to improve signal detection. We also tested all of the monoclonal antibodies within a heat stable fraction. This method is routinely used by many groups for Western blotting or to measure total tau after passive immunization, as this procedure very effectively removes any mouse Igs. The heat-stable procedure is based on the fact that tau is an extremely heat stable protein. Here, the non-specific signal seen in TKO mice was completely absent in the heat stable fraction, as expected. However, this technique also seems to decrease the overall tau signal and resolution on a Western blot, as evidenced by the observation that some antibodies failed to reveal all the bands of murine tau in the HS fraction. Furthermore, our results show that there is a significant fraction of tau lost into the pellet, and that this technique is not for studying proteins other than tau, such as kinases, as they were absent from the HS fraction. We further tested two others techniques to clear Igs. We took advantages of the capacity of protein G and Dynabeads to bind the fragment crystallizable region of mouse Igs in order to clear the samples of endogenous Igs. Results with cleared samples showed that the non-specific band in TKO mice was completely eliminated, further confirming that the non-specificity is due to mouse Igs. Both methods can be used to remove the nonspecificity but they involve significant modification of Western blot procedures and are more time-consuming than the simple replacement of secondary antibodies. Furthermore, it is possible that some proteins of interest could form a complex with protein G or Dynabeads and be discarded in the pellet. Finally, we tested some polyclonal antibodies and, as expected, our results indicate that these antibodies were not associated with specificity-related problems secondary to endogenous Igs. Nevertheless, in our study, some polyclonal antibodies, particularly the pS262 and pS409 antibodies, led to high non-specificity that obscured the tau signal detection. These antibodies displayed high non-specificity mainly due to their cross-reactivity with others proteins in the samples. While the HS treatment improved the phospho-tau signal of pS262, it did not for pS409. Indeed some studies have shown that pS409 is not phosphorylated in the human and rat adult brain, which could explain this problem with detection. In conclusion, this study provides evidence that both monoclonal and polyclonal antibodies can display non-specificity in mouse samples during Western blot analysis for tau protein.

These results are consistent with the concept that increasing intracellular LC-CoA levels leads to enhanced Ca2+ influx through TRPV1 channels. The potential significance of our findings to health and disease still remains to be comprehensively determined in future studies. However, it is important to speculate how this LC-Acyl CoA/ TRPV1 axis might contribute to both cellular function and dysfunction. Any alterations in Ca2+ signalling due to increased TRPV1 channel function could result in detrimental effects on a variety of cellular processes. For example, TRPV1 channel activation is thought to result in the secretion of substance P and calcitonin gene-related peptide that exert pro-inflammatory effects. Application of capsaicin concentrations that desensitize TRPV1 channels result in a decrease in pain and levels of these inflammatory peptides. TRPV1 antagonists are currently being developed to address a wide variety of diseases. Interestingly, low-grade inflammation is now thought to be a central component in the development of T2D diabetes, a disease in which fatty acid metabolism is perturbed. TRPV1 is also suggested to play a direct role in immune/inflammatory cell activation as TRPV1 channels are expressed in macrophages, dendritic cells and T-cells resulting in an increase in the levels of pro-inflammatory mediators including IL-1b, IL-6, IL-12 and TNF-a. Therefore any mechanism that leads to excessive TRPV1 channel activity may play a role in immune/inflammatory disorders. Given the potentially important role that inflammation plays in the etiology of obesity and metabolic disorders, excessive TRPV1 activity may be involved. Indeed, exposure of rodents to capsaicin-containing diet resulted in a leaner phenotype. In addition, WT mice fed a high fat diet weeks gained significantly more weight than TRPV1 knockout mice. TRPV1 knockout mice on a HFD also showed improved glucose tolerance compared to WT mice on a HFD. Collectively these findings suggest that excessive TRPV1 activation may be a contributing mechanism to the development of obesity and T2D. It is tempting to speculate that increased LC-CoA-mediated TRPV1 channel activation may occur via changes in fatty acid metabolism and transport observed in T2D and obesity where dietary consumption of saturated fatty acids is a contributory factor. In summary, our study reports a novel mechanism by which physiological concentrations of intracellular LC-CoA potently modulate TRPV1 channel via a mechanism similar, but not identical to PIP2. As many TRP family members are regulated by PIP2, our results reveal a metabolically-linked mechanism by which TRP channels activity may be regulated. This mechanism may contribute to the cellular dysfunction observed in immune/ inflammatory cell types in certain metabolic disorders that display altered fatty metabolism such as T2D and obesity. Further studies to test this concept are therefore warranted.